Order Article Reprints

Cabanu S, Pilar-Cuéllar F, Zubakina P, Florensa-Zanuy E, Senserrich J, Newman-Tancredi A, Adell A. Molecular Signaling Mechanisms for the Antidepressant Effects of NLX-101, a Selective Cortical 5-HT_1A Receptor Biased Agonist. Pharmaceuticals. 2022; 15(3):337. https://doi.org/10.3390/ph15030337

Cabanu, Sharon, Fuencisla Pilar-Cuéllar, Paula Zubakina, Eva Florensa-Zanuy, Júlia Senserrich, Adrian Newman-Tancredi, and Albert Adell. 2022. "Molecular Signaling Mechanisms for the Antidepressant Effects of NLX-101, a Selective Cortical 5-HT_1A Receptor Biased Agonist" Pharmaceuticals 15, no. 3: 337. https://doi.org/10.3390/ph15030337

Cabanu, S., Pilar-Cuéllar, F., Zubakina, P., Florensa-Zanuy, E., Senserrich, J., Newman-Tancredi, A., & Adell, A. (2022). Molecular Signaling Mechanisms for the Antidepressant Effects of NLX-101, a Selective Cortical 5-HT_1A Receptor Biased Agonist. Pharmaceuticals, 15(3), 337. https://doi.org/10.3390/ph15030337